Previous 10 | Next 10 |
2023-04-20 06:31:38 ET Novartis ( NYSE: NVS ) said early and continuous treatment with Kesimpta for up to five years in patients with relapsing multiple sclerosis (RMS) showed fewer disability worsening events and low brain volume change versus those who started on Sanofi's Aub...
2023-04-19 06:39:26 ET Summary Biotechnology is the second worst performer in healthcare, significantly lagging behind the US market year-to-date. However, there could now be opportunities to get a bargain in the biotechs. Kura Oncology may be of interest to investors as this US b...
2023-04-17 22:15:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-04-16 06:30:42 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Finding the best pharma stocks to sell can be an all-or-nothing kind of business. If you score on a company making a breakthrough in a new drug or treatment, the rewards can be extrem...
2023-04-14 11:28:52 ET Summary Pharmaceuticals/biotechnology is the only subsector with good value and quality scores. Healthcare equipment is the most overvalued one. IXJ: A global alternative to XLV. 10 stocks cheaper than their peers in April. This monthly art...
2023-04-11 10:41:37 ET TG Therapeutics ( NASDAQ: TGTX ) shares rallied for the second straight session on Tuesday to reach a new 52-week high after B. Riley Securities cited a rising trend in demand for the company’s newly approved multiple sclerosis therapy Briumvi. In D...
2023-04-08 07:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Shares of Novartis AG (NYSE: NVS) traded at a new 52-week high today and are currently trading at $96.24. So far today, approximately 956.02k shares have been exchanged, as compared to an average 30-day volume of 2.65M shares. Novartis AG researches, develops, manufactures, and markets health...
2023-04-04 04:35:28 ET The European Commission (EC) approved Novartis' ( NYSE: NVS ) citrate-free high concentration formulation (HCF; 100 mg/mL) of Hyrimoz (adalimumab), a biosimilar to AbbVie's ( NYSE: ABBV ) blockbuster drug Humira. Swiss pharma giant's generic...
2023-04-02 08:49:17 ET Summary Shares of gene therapy concern Voyager Therapeutics, Inc. have moved up more than 25% in 2023 on a couple of licensing deals. Last month, Novartis exercised an option to license Voyager's novel capsids for use in gene therapy programs against two und...
News, Short Squeeze, Breakout and More Instantly...
2024-07-19 04:04:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-18 16:45:16 ET Image source: The Motley Fool. Novartis Ag (NYSE: NVS) Q2 2024 Earnings Call Jul 18, 2024 , 8:00 a.m. ET Operator Continue reading For further details see: Novartis Ag (NVS) Q2 2024 Earnings Call Transcript
2024-07-18 14:15:34 ET By most standards shares of drugmaker Novartis (NYSE: NVS) should be higher following this morning's release of its second-quarter results. The drugmaker's top and bottom lines were both better than expected, and up from year-earlier comparisons. And profit gu...